Suppr超能文献

成人发作型II型瓜氨酸血症患者活体供体辅助性部分原位肝移植的可行性

Feasibility of auxiliary partial orthotopic liver transplantation from living donors for patients with adult-onset type II citrullinemia.

作者信息

Yazaki Masahide, Hashikura Yasuhiko, Takei Yo-ichi, Ikegami Toshihiko, Miyagawa Shin-ichi, Yamamoto Kanji, Tokuda Takahiko, Kobayashi Keiko, Saheki Takeyori, Ikeda Shu-ichi

机构信息

Third Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.

出版信息

Liver Transpl. 2004 Apr;10(4):550-4. doi: 10.1002/lt.20131.

Abstract

More than 20 patients with adult-onset type II citrullinemia have undergone liver transplantation, showing dramatic therapeutic effects. In Japan, living donor liver transplantation is the standard technique of liver transplantation because of the rare availability of cadaveric donors. The feasibility of auxiliary partial orthotopic liver transplantation (APOLT) for adult-onset type II citrullinemia to overcome the problem of a small-for-size graft in living donor liver transplantation has not been defined. We recently performed APOLT for patients with type II citrullinemia. Here, we present 2 patients: patient 1 was a 32-year-old man and patient 2 was a 43-year-old woman. Both patients suffered from hepatic encephalopathy, and laboratory data showed highly elevated plasma levels of ammonia and citrulline. In patient 1, the liver graft was obtained from a patient with familial amyloid polyneuropathy as a domino liver transplant. In patient 2, APOLT was performed after graft donation from her husband. The postoperative clinical courses of both patients were uneventful, and the neurological symptoms were completely resolved. The plasma concentrations of ammonia and citrulline normalized rapidly in both patients. APOLT can provide an adequate hepatocyte mass to correct the underlying enzyme deficiency in adult patients with type II citrullinemia. In addition, APOLT can be carried out safely to overcome the limitation of graft volume in living donor liver transplantation.

摘要

20 多名成年发病的 II 型瓜氨酸血症患者接受了肝移植,显示出显著的治疗效果。在日本,由于尸体供体稀缺,活体供肝移植是肝移植的标准技术。辅助性部分原位肝移植(APOLT)用于成年发病的 II 型瓜氨酸血症以克服活体供肝移植中移植物过小问题的可行性尚未明确。我们最近为 II 型瓜氨酸血症患者实施了 APOLT。在此,我们介绍 2 例患者:患者 1 是一名 32 岁男性,患者 2 是一名 43 岁女性。两名患者均患有肝性脑病,实验室数据显示血浆氨和瓜氨酸水平大幅升高。在患者 1 中,肝移植物取自一名患有家族性淀粉样多神经病的患者作为多米诺肝移植。在患者 2 中,在其丈夫进行供肝后实施了 APOLT。两名患者术后临床过程平稳,神经症状完全缓解。两名患者血浆氨和瓜氨酸浓度迅速恢复正常。APOLT 可为成年 II 型瓜氨酸血症患者提供足够的肝细胞数量以纠正潜在的酶缺乏。此外,APOLT 可以安全实施以克服活体供肝移植中移植物体积的限制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验